TapewireFind a company

person · Reporting owner

GRAMMER ELIZABETH A

Disclosed activity across 2 companies

Tapewire entity
38095
SEC CIK
0001213041

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ARDELYX, INC.ARDX · Entity 4972See RemarksNovember 21, 2025November 25, 2025
Sagimet Biosciences Inc.SGMT · Entity 5273DirectorJune 12, 2026June 15, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ARDELYX, INC.

Report date November 21, 2025 · Filed November 25, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect299,895 Reported balance After 2025-11-21 transaction · row 1
1 source row

Row 1 · 2025-11-21 · Sale · Disposed 5,995 · Balance 299,895

F1: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Sagimet Biosciences Inc.

Report date June 12, 2026 · Filed June 15, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.48 · Expires 2036-06-11Direct39,567 Reported balance After 2026-06-12 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-12 · Grant · Acquired 39,567 · Balance 39,567

F1: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 12, 2026 Filed Jun 15, 2026 20:20 UTC Sagimet Biosciences Inc. SGMT · Entity 5273 GrantStock Option (Right to Buy) · Derivative 39,567 $0.00 Strike: $6.48 $0.00
Disclosure

SEC source: 0001104659-26-074047 · tm2617570-3_4seq1.xml · derivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,567

Underlying: Series A Common Stock · 39,567 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
November 21, 2025 Filed Nov 25, 2025 21:44 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 5,995 $5.54 $33,193.72
Disclosure

SEC source: 0001610717-25-000397 · form4.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,895

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 21, 2025 Filed Aug 26, 2025 01:03 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 5,841 $5.93 $34,647.06
Disclosure

SEC source: 0001628280-25-041131 · wk-form4_1756170178.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,890

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
June 09, 2025 Filed Jun 10, 2025 21:36 UTC Sagimet Biosciences Inc. SGMT · Entity 5273 GrantStock Option (Right to Buy) · Derivative 32,250 $0.00 Strike: $5.33 $0.00
Disclosure

SEC source: 0001104659-25-058220 · tm2517621-1_4seq1.xml · derivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,250

Underlying: Series A Common Stock · 32,250 shares

Expires 2035-06-08

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
May 20, 2025 Filed May 23, 2025 01:50 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 5,992 $4.08 $24,455.75
Disclosure

SEC source: 0001628280-25-027425 · wk-form4_1747965021.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 311,731

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:56 UTC ARDELYX, INC. ARDX · Entity 4972 GrantStock Option (Right to Buy) · Derivative 205,019 $0.00 Strike: $5.18 $0.00
Disclosure

SEC source: 0001628280-25-008792 · wk-form4_1740696991.xml · derivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,019

Underlying: Common Stock · 205,019 shares

Expires 2035-02-25

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of February 25, 2025, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:56 UTC ARDELYX, INC. ARDX · Entity 4972 GrantCommon Stock 136,680 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-008792 · wk-form4_1740696991.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,723

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
February 20, 2025 Filed Feb 21, 2025 23:53 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 4,291 $5.62 $24,128.29
Disclosure

SEC source: 0001628280-25-007228 · wk-form4_1740181995.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,043

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · price: Transaction was executed in multiple trades in prices ranging from $5.601611 to $5.625428, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:24 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 7,046 $4.79 $33,782.05
Disclosure

SEC source: 0001628280-24-049049 · wk-form4_1732317858.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,334

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 20, 2024 Filed Aug 22, 2024 22:22 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 7,089 $5.86 $41,543.67
Disclosure

SEC source: 0001628280-24-038287 · wk-form4_1724365356.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,380

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:05 UTC Sagimet Biosciences Inc. SGMT · Entity 5273 GrantStock Option (Right to Buy) · Derivative 51,459 $0.00 Strike: $4.64 $0.00
Disclosure

SEC source: 0001104659-24-069626 · tm2416701-1_4seq1.xml · derivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,459

Underlying: Series A Common Stock · 51,459 shares

Expires 2034-06-04

F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 5, 2024, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
May 21, 2024 Filed May 23, 2024 20:10 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 6,927 $7.81 $54,106.80
Disclosure

SEC source: 0001628280-24-024935 · wk-form4_1716495028.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,469

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 2,636 shares under the Ardelyx Employee Stock Purchase Plan in February 2024.

Read SEC document
May 06, 2024 Filed May 9, 2024 20:03 UTC ARDELYX, INC. ARDX · Entity 4972 Exercise / conversionStock Option (Right to Buy) · Derivative 109,687 $0.00 Strike: $2.75 $0.00
Disclosure

SEC source: 0001610717-24-000235 · form4.xml · derivative · entry 6

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241,313

Underlying: Common Stock · 109,687 shares

Expires 2033-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
May 06, 2024 Filed May 9, 2024 20:03 UTC ARDELYX, INC. ARDX · Entity 4972 Exercise / conversionStock Option (Right to Buy) · Derivative 110,250 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001610717-24-000235 · form4.xml · derivative · entry 5

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,750

Underlying: Common Stock · 110,250 shares

Expires 2032-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
May 06, 2024 Filed May 9, 2024 20:03 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 219,937 $8.88 $1,952,380.75
Disclosure

SEC source: 0001610717-24-000235 · form4.xml · nonDerivative · entry 4

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 203,760

F1 · price: This transaction was executed in multiple trades in prices ranging from $8.63 to $9.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
May 06, 2024 Filed May 9, 2024 20:03 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 64,233 $8.87 $569,836.64
Disclosure

SEC source: 0001610717-24-000235 · form4.xml · nonDerivative · entry 3

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 423,697

F1 · price: This transaction was executed in multiple trades in prices ranging from $8.63 to $9.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
May 06, 2024 Filed May 9, 2024 20:03 UTC ARDELYX, INC. ARDX · Entity 4972 Exercise / conversionCommon Stock 109,687 $2.75 $301,639.25
Disclosure

SEC source: 0001610717-24-000235 · form4.xml · nonDerivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 487,930

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 06, 2024 Filed May 9, 2024 20:03 UTC ARDELYX, INC. ARDX · Entity 4972 Exercise / conversionCommon Stock 110,250 $0.99 $109,147.50
Disclosure

SEC source: 0001610717-24-000235 · form4.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378,243

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2024 Filed May 7, 2024 22:24 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 45,000 $9.00 $405,000.00
Disclosure

SEC source: 0001610717-24-000233 · form4.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 267,993

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2023.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:42 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 86,000 $7.73 $664,977.80
Disclosure

SEC source: 0001610717-24-000182 · form4.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 312,993

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $7.65 to $7.92, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:57 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 4,432 $8.75 $38,763.60
Disclosure

SEC source: 0001610717-24-000083 · form4.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 398,993

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:34 UTC ARDELYX, INC. ARDX · Entity 4972 GrantStock Option (Right to Buy) · Derivative 164,000 $0.00 Strike: $8.78 $0.00
Disclosure

SEC source: 0001628280-24-001680 · wk-form4_1705613639.xml · derivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,000

Underlying: Common Stock · 164,000 shares

Expires 2034-01-16

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 21:34 UTC ARDELYX, INC. ARDX · Entity 4972 GrantCommon Stock 127,750 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-001680 · wk-form4_1705613639.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 403,425

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
December 11, 2023 Filed Dec 13, 2023 22:44 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 50,000 $5.08 $253,925.00
Disclosure

SEC source: 0001628280-23-041479 · wk-form4_1702507443.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 275,675

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $4.99 to $5.27, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 22:19 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 2,384 $4.36 $10,399.48
Disclosure

SEC source: 0001628280-23-039900 · wk-form4_1700691550.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,675

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 21, 2023 Filed Aug 23, 2023 20:39 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 2,392 $3.55 $8,495.91
Disclosure

SEC source: 0001628280-23-030399 · wk-form4_1692823171.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 328,059

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · price: This transaction was executed in multiple trades in prices ranging from $3.511 to $3.551843, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:15 UTC Sagimet Biosciences Inc. SGMT · Entity 5273 GrantStock Option (Right to Buy) · Derivative 49,533 $0.00 Strike: $8.74 $0.00
Disclosure

SEC source: 0001104659-23-082720 · tm2321276-13_4seq1.xml · derivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,533

Underlying: Series A Common Stock · 49,533 shares

Expires 2031-04-19

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: The shares underlying this option vest in forty-eight (48) equal monthly installments following April 16, 2021, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:15 UTC Sagimet Biosciences Inc. SGMT · Entity 5273 Disposition to issuerStock Option (Right to Buy) · Derivative 49,533 $0.00 Strike: $8.74 $0.00
Disclosure

SEC source: 0001104659-23-082720 · tm2321276-13_4seq1.xml · derivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 49,533 shares

Expires 2031-04-19

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: The shares underlying this option vest in forty-eight (48) equal monthly installments following April 16, 2021, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
May 23, 2023 Filed May 25, 2023 12:54 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 2,384 $3.65 $8,709.23
Disclosure

SEC source: 0001104659-23-064393 · tm2316962-6_4seq1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,451

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 2,881 shares under the Ardelyx Employee Stock Purchase Plan in February 2023.

Read SEC document
February 21, 2023 Filed Feb 24, 2023 22:39 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 2,914 $3.00 $8,744.91
Disclosure

SEC source: 0001567619-23-003772 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 329,954

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:26 UTC ARDELYX, INC. ARDX · Entity 4972 GrantStock Option (Right to Buy) · Derivative 351,000 $0.00 Strike: $2.73 $0.00
Disclosure

SEC source: 0001567619-23-000647 · doc1.xml · derivative · entry 3

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,000

Underlying: Common Stock · 351,000 shares

Expires 2033-01-05

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:26 UTC ARDELYX, INC. ARDX · Entity 4972 GrantCommon Stock 78,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-000647 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,868

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
November 22, 2022 Filed Nov 23, 2022 21:16 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 1,193 $1.95 $2,325.51
Disclosure

SEC source: 0001567619-22-020849 · doc1.xml · nonDerivative · entry 3

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,868

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 22, 2022 Filed Nov 23, 2022 21:16 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 20 $1.95 $38.90
Disclosure

SEC source: 0001567619-22-020849 · doc1.xml · nonDerivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 256,061

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 22, 2022 Filed Nov 23, 2022 21:16 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 29 $1.94 $56.30
Disclosure

SEC source: 0001567619-22-020849 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 256,081

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 31, 2022 Filed Sep 1, 2022 23:02 UTC ARDELYX, INC. ARDX · Entity 4972 PurchaseCommon Stock 3,000 $0.62 $1,856.40
Disclosure

SEC source: 0001567619-22-016955 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 256,110

F1 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2022.

Read SEC document
August 22, 2022 Filed Aug 24, 2022 21:43 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 9 $0.98 $8.82
Disclosure

SEC source: 0001567619-22-016643 · doc1.xml · nonDerivative · entry 3

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,110

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 22, 2022 Filed Aug 24, 2022 21:43 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 2 $0.98 $1.96
Disclosure

SEC source: 0001567619-22-016643 · doc1.xml · nonDerivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,119

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
August 22, 2022 Filed Aug 24, 2022 21:43 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 1,225 $0.98 $1,205.03
Disclosure

SEC source: 0001567619-22-016643 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,121

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
June 06, 2022 Filed Jun 9, 2022 00:01 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 1,260 $0.64 $800.86
Disclosure

SEC source: 0001567619-22-012554 · doc1.xml · nonDerivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,346

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
June 06, 2022 Filed Jun 9, 2022 00:01 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 59,561 $0.65 $38,768.25
Disclosure

SEC source: 0001567619-22-012554 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,606

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
May 20, 2022 Filed May 23, 2022 20:31 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 1,263 $0.67 $847.98
Disclosure

SEC source: 0001567619-22-011517 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,167

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
February 22, 2022 Filed Feb 25, 2022 21:56 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 1,528 $0.67 $1,023.76
Disclosure

SEC source: 0001567619-22-005661 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 316,430

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
January 06, 2022 Filed Jan 13, 2022 00:46 UTC ARDELYX, INC. ARDX · Entity 4972 GrantStock Option (Right to Buy) · Derivative 196,000 $0.00 Strike: $0.99 $0.00
Disclosure

SEC source: 0001567619-22-001137 · doc1.xml · derivative · entry 3

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,000

Underlying: Common Stock · 196,000 shares

Expires 2032-01-06

F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Read SEC document
January 06, 2022 Filed Jan 13, 2022 00:46 UTC ARDELYX, INC. ARDX · Entity 4972 GrantCommon Stock 42,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-001137 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 317,958

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:05 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 537 $0.99 $532.65
Disclosure

SEC source: 0001567619-21-021158 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,958

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
November 12, 2021 Filed Nov 13, 2021 00:09 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 77,432 $1.13 $87,111.00
Disclosure

SEC source: 0001567619-21-020115 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,495

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 28, 2021.

F2 · price: The transaction was executed in multiple trades in prices ranging from $1.11 to $1.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 08, 2021 Filed Oct 29, 2021 23:54 UTC ARDELYX, INC. ARDX · Entity 4972 GrantCommon Stock 250,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-019028 · doc1.xml · nonDerivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,927

F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,541 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021.

Read SEC document
August 20, 2021 Filed Aug 24, 2021 22:05 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 526 $1.32 $694.32
Disclosure

SEC source: 0001567619-21-016282 · doc1.xml · nonDerivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,386

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document
May 20, 2021 Filed May 21, 2021 20:46 UTC ARDELYX, INC. ARDX · Entity 4972 SaleCommon Stock 508 $7.09 $3,600.60
Disclosure

SEC source: 0001567619-21-010920 · doc1.xml · nonDerivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,912

F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.